UPSTAZA 2.8 x 100 000 000 000 génomes de vecteur (vg)/0.5 ml, solution for infusion bottle, 0.5 ml
Active ingredients: ÉLADOCAGÈNE EXUPARVOVEC
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for infusionbottle, 0.5 mlintraputaminale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- UPSTAZA 2,8 x 100 000 000 000 génomes de vecteur (vg)/0,5 mL, solution pour perfusion
- Pharmaceutical form
- solution pour perfusion
- Route of administration
- intraputaminale
- Presentation description
- 1 flacon(s) en verre de 0,5 mL
- Marketing authorisation holder
- PTC THERAPEUTICS INTERNATIONAL (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Jan 2023
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
61876862CIP75508956CIP133400955089568Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉLADOCAGÈNE EXUPARVOVECsolution | 2,8 x 10^11 génomes de vecteur · 0,5 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.